Cargando…
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight
The Arterial Revascularization Therapy Study (ARTS) and the Stent or Surgery (SoS) trial each randomized patients with multivessel disease to either stenting or bypass surgery. The ARTS showed no difference in mortality between the two strategies, other than in diabetic patients, who fared better wi...
Autores principales: | Bhatt, Deepak L, Topol, Eric J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64821/ https://www.ncbi.nlm.nih.gov/pubmed/11806809 http://dx.doi.org/10.1186/cvm-2-6-260 |
Ejemplares similares
-
Debate: PCI vs CABG: a moving target, but we are gaining
por: Holmes, David R
Publicado: (2001) -
PCI or CABG, That is the Question!
por: Woo, Jong Shin, et al.
Publicado: (2017) -
Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG
por: Eifert, Sandra, et al.
Publicado: (2010) -
Evidence based decision making between PCI and CABG
por: Collet, Carlos
Publicado: (2019) -
Multivessel versus culprit-only PCI in STEMI patients with multivessel disease: meta-analysis of randomized controlled trials
por: Feistritzer, Hans-Josef, et al.
Publicado: (2020)